Reversed Phase
- 1: Comparison of STYROS™ 1R and 2R with a Silica C4 Stationary Phase.
- 2: Fast Protein Separation on STYROS™ 1R and 2R.
- 3: Comparison of STYROS™ 1R/XP and 1R/XH.
- 4: Separation of Angiotensin Variants at Basic pH.
- 5: High Performance Separation of Proteins on STYROS™ 1R/NB
- 6: Ultra Fast Separation of Proteins on Narrow Bore Columns.
- 25: Fast Detection of XELODA (Capecitabine) in Urine Sample with STYROS™ 2R/XH.
- 33: ADRIAMYCIN: Detection in Urine Sample with STYROS™ 2R/XH
- 35: NAVELBINE: Fast Detection in Urine Sample with STYROS™ 2R/XH.
- 40: Hydrophobic Interaction Chromatography compared with Polymeric Reversed Phase: STYROS™ HIC-Butyl versus STYROS™ 2R.
- 49: STYROS™ 3R Simulated Monolith Polymeric Reversed Phase.
- 50: STYROS™ 3R Simulated Monolith Polymeric Reversed Phase: Standard Separation of 6 Small Molecules
- 58: STYROS™ 3R Simulated Monolith™ Polymeric Reversed Phase: Loadability Study, Comparison with Silica Reversed Phases
- 91: STYROS™ 3R Simulated Monolith™ Polymeric Reversed Phase. Protein Standard Separation at High Linear Velocity
- 108: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Comparing Narrow Bore column with a
standard Bore of 4.6 mm ID - 109: STYROS® Simulated-Monolith™ Polymeric Reversed Phase. Fast convective channels of monolith to separate different size molecules in a mixture
- 110: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Separation of 5 peptides on Narrow Bore column of 2.1 mm ID. Acidic and Basic pH’s
- 111: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Separation of 5 peptides on Micro Bore column of 1 mm ID. Acidic and Basic pH’s
- 112: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Separation of 5 proteins standard on Micro Bore column of 1 mm ID. Comparison with Narrow Bore of 2.1 mm ID
- 113: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Separation of 4 proteins standard on Capillary column of 0.5 mm ID. Comparison with Micro Bore of 1 mm ID
- 114: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Separation of 4 parabens on Capillary column of 0.5 mm ID. Comparison with Micro Bore of 1 mm ID
- 115: STYROS®2R Simulated-Monolith™ Polymeric Reversed Phase. Assessment of columns prior to use
- 116: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Separation of 9 Phenones on Capillary column of 0.5 mm ID
- 117: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Separation of 9 Phenones on Micro Bore column of 1 mm ID
- 118: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Separation of 9 Phenones on Narrow Bore column of 2.1 mm ID
- 119: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Use of Micro Bore column of 1 mm ID using high and low pH’s to separate Sulfa drugs and precursor
- 120: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Use of Capillary column of 0.5 mm ID using high and low pH’s to separate Sulfa drugs and precursor
- 121: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Use of Narrow Bore column of 2.1 mm ID using high and low pH’s to separate Sulfa drugs and precursor
- 122: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Use of Narrow Bore column of 2.1 mm ID using high pH’s to separate 5 Chlorophenols
- 123: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Advantages of using Narrow Bore instead of Normal Bore columns for LC separations.
- 125: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase. Advantages of using Narrow Bore instead of Normal Bore columns for LC separations.
- 126: STYROS® 2R Simulated-Monolith™ Polymeric Reversed Phase Narrow Bore: Comparison with the narrow bore column of the leading manufacturer.
- 127: STYROS® Simulated-Monolith™ Polymeric Reversed Phase. Performance of PS-DVB stationary phase of different manufacturers with Methanol.
- 129: STYROS® R Simulated-Monolith™ Reversed Phases. Alternative Performances
- 131: Reversed Phase Separations of gamma-Globulin from Serum Albumin (bovine and human blood) using Narrow Bore Columns and MeOH
- 167: Assessing Narrow Bore Reversed Phase Columns
- 178: STYROS® HQ, Strong Anion Exchanger, Compared with STYROS® 1R Reversed Phase Polymeric. A line of Stable Polymeric Simulated-Monolith™ to Replace Slow and Leaching Soft Gels.
- 180: Simulated-Monolith™, a line of stable Polymeric that Allows Universal Separations of Different Molecules Size through Rapid Convection.
- 181: Simulated-Monolith™, Beyond Monolith. A Line of Stable Polymeric that Allows Universal Separations Convectively Fast to Accommodate the Speed and Scale of Vaccine Production at All Times Particularly During Pandemic Avoiding the Unnecessary Step of Polishing.
- 182: Simulated-Monolith™ Polymerics, Compared with Non-Porous Polymerics.
- 183: Simulated-Monolith™ Polymerics, Compared with Non-Porous Polymerics. Isocratic Run in ACN.
- 184: Simulated-Monolith™ Polymerics, Compared with Non-Porous Polymerics. Gradient Run in MeOH.
- 185: Comparing STYROS® 1R With PLRP-S.
- 186: 0.50 meter long, 1 mm ID column with Simulated-Monolith™ STYROS® polymerics.
- 198: Simulated-Monolith™ STYROS® polymerics compared with Pellicular 3 µm polymeric.
Anion Exchanger
- 7: Quality Control of Proteins of Different Lots from the Same Supplier.
- 8: Assessing Proteins Across Grades and Suppliers.
- 9: Polymeric Hard Gel Media-HPLC vs. Soft Gel-FPLC in the Separation of Biomolecules.
- 10: Fast Separation of Protein Isoforms with Fully Porous Hard Gel Media: Hemoglobins.
- 11: Polymeric Gigaporous Strong Anion Exchangers: Bead Size Distribution versus Pore Size Distribution.
- 13: High Speed Resolution: Efficient Use of Long, Narrow-bore Columns.
- 16: Polymeric Gigaporous Anion Exchanger: Throughpores versus Superficial Pores.
- 17: Polymeric Gigaporous Anion Exchanger : Performance at Low Flow Rates.
- 18: Separation of Small Molecules on STYROS™ Q/XH.
- 23: Fast Separation of IgG on STYROS™ HQ: High Capacity Polymeric Gigaporous Strong Anion Exchanger.
- 24: Fast Separation of IgG, IgA and IgM on STYROS™ DEAE/NB: Narrow Bore Weak Anion Exchanger.
- 37: Separation of Aprotinin from apo-Transferrin and Hexokinase on Polymeric Hard Gel Anion Exchange Columns.
- 38: Aprotinin Purity Test on STYROS™ Anion and Cation Exchanger. Polymeric Hard Gel Stationary Phase.
- 46: Separation of Hen Egg White Proteins: STYROS™ HQ Compared with Mono Q
- 48: Low Salt Separations on Shielded Weak Anion Exchanger: STYROS™ SWAX
- 59: Quaternary Amino Methyl (HQ) Anion Exchanger: Comparison with Mono Q
- 60: Quaternary Amino Methyl (HQ) Anion Exchanger: Beyond Mono Q
- 61: Quaternary Amino Ethyl (QAE) Anion Exchanger: Column Lenght
- 62: Quaternary Amino Ethyl (QAE) Anion Exchanger: Comparison with Quaternary Amino Methl (HQ)
- 79: STYROS™ HQ Simulated Monolith™ Polymeric: Separation of Protein Mixtures
- 80: STYROS™ HQ Simulated Monolith™ Polymeric: Loading Study
- 81: Practical Use of STYROS™ HQ Simulated Monolith™ Polymeric In the Separation of Hemoglobin Variants
- 82: Separation of Soybean Trypsin Inhibitor wiht STYROS™ HQ Simulated Monolith™ Polymeric
- 83: Practical Use of STYROS™ HQ Simulated Monolith™ Polymeric In the Separation of OVA Variants
- 84: Practical Use of STYROS™ HQ Simulated Monolith™ Polymeric In the Separation of Hemoglobin and Methemoglobin
- 85: Use of STYROS™ HQ Simulated Monolith™ Polymeric in the Quality Control of Incoming Lots
- 86: STYROS™ HQ Simulated Monolith™ Polymeric. Importance of Column Length
- 87: Practical Use of STYROS™ HPA Simulated Monolith™ Polymeric In the Separation of OVA Variants
- 88: Practical Use of STYROS™ HPA Simulated Monolith™ Polymeric In the Separation of Hemoglobin Variants
- 89: Practical Use of STYROS™ HPA Simulated Monolith™ Polymeric In the Separation of Hemoglobin and Methemoglobin
- 90: Comparison of STYROS™ HPA Anion Exchanger with STYROS™ 3R Reversed Phase In the Assessment of Commercial OVA
- 97: Separation of Pancreatin on STYROS™ HPA (High Capacity Weak Anion Exchanger): Column Length
- 98: Separation of Pancreatin on STYROS™ DEAE (Weak Anion Exchanger, Diethyaminoethyl ):Simulated-Monolith™ and Column Length
- 99: Separation of Pancreatin on STYROS™ HQ (Strong Anion Exchanger ): Simulated-Monolith™ and Column Length
- 100: Separation of Pancreatin on STYROS™ QAE (Strong Anion Exchanger ): Simulated-Monolith™ and Column Length
- 101: Separation of Pancreatin on STYROS™ Q (Strong Anion Exchanger ): Simulated-Monolith™ and Column Length
- 102: Separation of Pancreatin on STYROS™ PA (Weak Anion Exchanger ): Simulated-Monolith™ andColumn Length
- 176. STYROS® HQ Simulated-Monolith™ Polymeric Compared with Commercial POROUS HQ.
- 177. STYROS® HQ, Strong Anion Exchanger, Compared with STYROS® HPA Weak Anion Exchanger.
Cation Exchanger
- 12: Polymeric Gigaporous Strong Cation Exchangers: Bead Size Distribution versus Pore Size Distribution.
- 14: Polymeric Gigaporous Strong Cation Exchangers: Effect of Capacity on Protein Resolution.
- 15: Separation of IgG from Albumins in Commercial Production.
- 19: Resolving Efficiency of Longer Columns: case application with medium capacity cation exchanger.
- 22: Separation of Cytochrome c Isoform on STYROS™ SE: Strong cation exchanger.
- 38: Aprotinin Purity Test on STYROS™ Anion and Cation Exchanger. Polymeric Hard Gel Stationary Phase.
- 92: STYROS™ SP Simulated Monolith™ Strong Cation Exchangers: Loadability and Linear Velocity
- 93: STYROS™ SP Simulated Monolith™ Strong Cation Exchangers: Longer Columns for Added Resolution
- 94: STYROS™ SP Simulated Monolith™ Strong Cation Exchanger Compared to CM Simulated Monolith™ Weak Cation Exchanger
- 95: STYROS™ SP Simulated Monolith™ Strong Cation Exchanger Compared to CM Simulated Monolith™ Weak Cation Exchanger. Sequence of Protein Elution
- 96: STYROS™ Simulated-Monolith.. Choice of the Right Column.
Affinity
- 20: Metal Chelate Liquid Chromatography on Hard Gel Gigaporous Polymeric Media: Comparison with Soft Gel.
- 21: Metal Chelate Liquid Chromatography on Hard Gel Gigaporous Polymeric Media: Tri-dentate IDA versus Five-dentate TED
- 32: Rapid isolation of IgG From Human Serum on STYROS™ rA (Immobilized Recombinant Protein A on Simulated Monolith™ Polymeric Stationary Phase).
- 34: Immobilized Protein rA on Polymeric Porous Hard Gel (STYROS™ rA): Comparison with Sepharose rA.
- 65: Quantitation of Monoclonal Antibodies with Immobilized Protein rA on Simulated Monolith™ Polymeric STYROS™
- 66: Assessing Monoclonal Antibodies (mAB) with Immobilized Protein rA on Simulated Monolith™ Polymeric STYROS™: Dynamic Capacity.
Enzyme Columns
- 26: StyrosZyme™ TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Stationary Phase: Online Digestion of Lysozyme in 5 minutes.
- 27: StyrosZyme™ TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Stationary Phase: Online Digestion of Insulin Oxidized B-chain in 16 minutes.
- 28: StyrosZyme™ Pepsin, Immobilized Enzyme on Polymeric Hard Gel Stationary Phase: On line digestion of Cytochrome c From Horse Heart and Bovine Heart.
- 31: StyrosZyme™ Papain, Immobilized Enzyme on Simulated Monolith Polymeric Stationary Phase: Effect of Temperature and Linear Velocity on Online Digestion.
- 36: On Line Affinity capture of APROTININ on StyrosZyme™ TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Stationary Phase.
- 39: StyrosZyme™ Pepsin. Immobilized Enzyme on Polymeric Hard Gel Stationary Phase: On line digestion at 0 °C and pH 2.5.
- 63: StyrosZyme™ Pepsin, Immobilized Enzyme on Polymeric Hard Gel Stationary Phase: On line digestion of Cytochrome c From Horse Heart and Bovine Heart. Alternative
- 64: StyrosZyme™ Pepsin, Immobilized Enzyme on Polymeric Hard Gel Stationary Phase: On line digestion of Cytochrome c and Myoglobin From Horse Heart.
- 124: StyrosZyme® Pepsin, Immobilized Enzyme on Simulated-Monolith™ Polymeric Hard Gel: Full on line digestion of a of solution of 10 µl of 10 mg/ml protein.
- 132: StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™. Automation of the Digestion and Mapping of Cytochrome c.
- 133: StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™. Effect of Different Variables on Automated Digestion.
- 134: Automated Digestion with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™. Effect of Linear Velocity and Column Length on the Digestion of Oxidized Insulin B Chain.
- 135: Automated Digestion with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™. Stability of the Enzyme Reactor in Yielding Reproducible Results in Automation.
- 136:Automated Digestion with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™. Digestion and mapping of 3 µg of protein on Narrow Bore column.
- 137: Automated Digestion with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™. Digestion and mapping of 10 µg of Lysozyme on Narrow Bore column.
- 139: Automated Digestion with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor. Use of a 10 port valve to minimize salt exposure to the Mass. Spectrometer.
- 140: Automated Digestion and mapping with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus.
- 141: Automated Digestion and Silica mapping with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus.
- 142:Automated Digestion of Trypsin with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Silica mapping.
- 143. Comparing digests of Cytochrome c from Bovine with Equine with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final mapping on Silica C18. Fully Automated.
- 144. Enzyme auto-digestion during batch mode processes. Assessment of the level of contamination comparing it to the digests of Cytochrome c from equine as an example.
- 145. Automated Digestion of Horse Heart Myoglobin and Horse Skeletal Muscle Myoglobin using the Acquity UPLC I class Plus and the Acquity UPLC® BEH C18 1.7 µm 2.1×50 cm column as the final Reversed Phase Column.
- 146. Testing StyrosZyme® TPCK-Trypsin Column’s Activity Using Insulin B Chain. Fully Automated Using Waters Acquity UPLC I class Plus.
- 153.Automated Digestion of Trypsin with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica mapping. Result of excess injection of Trypsin on the Trypsin column.
- 155.Automated digestion of Cytochrome c from bovine compared with Equine with StyrosZyme® Pepsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping
- 156. Automated digestion of Cytochrome c from bovine compared with Equine with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping.http://orachrom.net/wp-content/uploads/2021/01/156-AN102520-Cyto-c-Trypsin.pdf
- 157. Pepsin digestion of Cytochrome c compared to TPCK-Trypsin digestion of same.
- 158. Automated digestion of Albumin from Bovine serum, Chicken egg and Human serum, using StyrosZyme® Pepsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme reactor with the Acquity UPLC I class Plus and Final Silica mapping
- 159. Gamma Globulin from bovine blood, Gamma Globulins from human blood digested with immobilize StyrosZyme® Pepsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme reactor with the Acquity UPLC I class Plus and Final Silica mapping.
- 160. Automated StyrosZyme® Pepsin digestion of Myoglobin from horse heart and horse skeletal muscle, with Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping
- 161. Automated StyrosZyme® Pepsin digestion of 2 types of Hemoglobin, with Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping
- 162.Background noise, not leaching enzyme.
- 163. Automated StyrosZyme® Pepsin digestion of Pepsin, with Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 164. Automated digestion of Goat IgG with StyrosZyme® Pepsin, an Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping
- 165. Automated digestion of Egg White on StyrosZyme® Pepsin, with Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping
- 166. Automated digestion of Cytochrome c from equine with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor. Comparison of binary with quaternary UPLC systems.
- 170. Automated Digestion of Trypsin with StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica mapping. Update of Application Note 153.
- 171. Impact of residency time on the extent of digestion. Case study of digestion of Human Hemoglobin with StyrosZyme® TPCK-Trypsin Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 172. Impact of residency time on the extent of digestion. Case study of digestion of Human Hemoglobin with StyrosZyme® TPCK-Trypsin Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 173. Digestion Limits of Human Serum Albumin with Trypsin. Case study of digestion of Human Serum Albumin with StyrosZyme® TPCK-Trypsin Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 174. Lysozyme. Impact of residency time on the extent of digestion. Case study of digestion of Lysozyme with StyrosZyme® TPCK-Trypsin Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 175. Transferrin. Impact of residency time on the extent of digestion. Case study of digestion of Transferrin with StyrosZyme® TPCK-Trypsin Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 179. Moving Past the Limits of Digestion of Human Serum Albumin with Trypsin, using DTT. Case study of digestion of Human Serum Albumin with StyrosZyme® TPCK-Trypsin Hard Gel Simulated- Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 187. Adding DTT to Fully Digest Trypsin Inhibitor with Immobilized TPCK-Trypsin. Case study of digestion with StyrosZyme® TPCK-Trypsin Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 188. Lysozyme Digestion. TPCK Derivatized Compared with Non-Derivatized Trypsin in Digesting Lysozyme.
- 189. Casein Digestion. TPCK Derivatized Compared with Non-Derivatized Trypsin in Digesting Fat Free Casein from bovine milk.
- 190. Comparing Tryptic digest from Bovine with Porcine, using StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor with the Acquity UPLC I class Plus and Final Silica mapping. Update of Application Notes 153 and 170.
- 191. Controlling the Automated Digestion of Cytochrome c by Controlling the Linear Velocity of the Flow Rates During the Online Digestion. StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor was used with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 192. Controlling the Automated Digestion of Cytochrome c by Controlling the pH During the Online Digestion. StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor was used with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 193. Assessing Chromatography Media’s Stability by Tethering Enzymes on them. Case Study: StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor used with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 194. Scale Up of the Enzymatic Process Using Stable Immobilized Enzymes. Case Study: StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor used with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 195. Enzyme Digestion in Batch Compared to Digestion Online. Case Study: StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor used with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 196. Digesting Free Enzymes with Immobilized Enzymes. Case Study: StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel SimulatedMonolith™ Enzyme Reactor used with the Acquity UPLC I class Plus and Final Silica C18 mapping.
- 199. Controlling the Online Digestion of Cytochrome c, by Controlling the Linear Velocity. Case Study: StyrosZyme® TPCK-Trypsin, Immobilized Enzyme on Polymeric Hard Gel Simulated-Monolith™ Enzyme Reactor used with the Acquity UPLC I class Plus and Final Silica C18 mapping.
HIC (Hydrophobic Interaction Chromatography)
- 29: SIMULATED MONOLITH™: Fast Separations with HIC (Hydrophobic Interaction Chromatography)
- 30: SIMULATED MONOLITH™: Comparison With Non Covalently Coated Polymeric Hard Gel.
- 40: Hydrophobic Interaction Chromatography compared with Polymeric Reversed Phase: STYROS™ HIC-Butyl versus STYROS™ 2R.
- 41: Hydrophobic Interaction Chromatography : Comparison of STYROS™ HIC-Phenyl with Shodex HIC PH-818.
- 42: Reversed Phase Polymeric: Comparison of STYROS™ 2R with Commercial Non Porous Polymeric.
- 43: Hydrophobic Interaction Chromatography: Comparison of STYROS™ HIC-Phenyl with TSKgel Phenyl-5PW from TOSOH.
- 44: Hydrophobic Interaction Chromatography: Comparison of STYROS™ HIC-Butyl with TSKgel Butyl-NPR from TOSOH.
- 45: Hydrophobic Interaction Chromatography: Comparison of STYROS™ HIC-Ether with TSKgel Ether-5PW from TOSOH.
- 67: Hydrophobic Interaction Chromatography: Facts
- 68: Hydrophobic Interaction Chromatography: With Limited Sample.
- 69: Hydrophobic Interaction Chromatography: Desalting and Concentration
- 70:Hydrophobic Interaction Chromatography: Separation of Various Snake Venoms.
- 128:Hydrophobic Interaction Chromatography: Separation of gamma-Globulin (bovine blood) from Bovine Serum Albumin. Loadability Study.
- 130:Hydrophobic Interaction Chromatography: Separation on Narrow Bore Columns of gamma-Globulin from Serum Albumin (bovine and human blood)
HILIC & Amino-HILIC (Hydrophylic Interaction Liquid Chromatography)
- 51: STYROS™ Amino HILIC Simulated Monolith Polymeric Normal Phase: Standard Separations.
- 52: STYROS™ Amino HILIC Simulated Monolith™ Polymeric: Separation of Benzoic Acid and Derivatives
- 53: STYROS™ Amino HILIC Simulated Monolith™ Polymeric: Effect of Ionic Strength and Temperature on the Separation of Aromatic Acids
- 54: STYROS™ Amino HILIC Simulated Monolith™ Polymeric: Separation of Angiotensins I, II and III
- 55: STYROS™ HILIC Simulated Monolith™ Polymeric Normal Phase: Standard Separations
- 56: STYROS™ HILIC Simulated Monolith Polymeric Normal Phase: Separation of Aliphatic and Aromatic Acids
- 57: STYROS™ HILIC Simulated Monolith Polymeric Normal Phase: Separation of Nucleotides
- 71: STYROS™ HILIC Simulated Monolith™ Polymeric Normal Phase: Separation of Nucleotdes Intended for MS. No Bleed
- 72: STYROS™ Amino-HILIC Simulated Monolith™ Polymeric Normal Phase: Separation of Purines and Pyrimidines Intended for MS. No Bleed
- 73: STYROS™ Amino-HILIC Simulated Monolith™ Polymeric Normal Phase: Separation of Purines and Pyrimidines on Narrow Bore Columns Intended for MS. No Bleed
- 74: STYROS™ Amino-HILIC Simulated Monolith™ Polymeric Normal Phase: Separation of Uracil and 5-Fluorouracil. Narrow Bore and Normal Bore Columns
- 75: STYROS™ Amino-HILIC Simulated Monolith™ Polymeric Normal Phase: Separation Nucleosides Intended for MS. No Bleed
- 76: STYROS™ HILIC Simulated Monolith™ Polymeric Normal Phase: Separation of Adrenaline and Noradrenaline Intended for MS. No Bleed
- 77: STYROS™ HILIC Simulated Monolith™ Polymeric Normal Phase: Separation of Dopamine and L-Dopa for MS. No Bleed
- 78: STYROS™ HILIC Simulated Monolith™ Polymeric Normal Phase: Separation of Methyladrenaline and Methyldopa Intended for MS.No Bleed
Heart-cutting
- 147:Heart-cutting Made Simple Using Acquity UPLC I class Plus.
- 148:Heart-cutting Made Simple Using Agilent 1290 Infinity.
Trap, Concentrate, Map.
- 149: Trap Concentrate and Map, Using Acquity UPLC I class Plus
- 150: Trap, Concentrate and Map, Using Acquity UPLC I class Plus. STYROS® R Polymeric Compared with C18 Acquity UPLC® BEH.
- 151:Trap, Concentrate and Map, Using Acquity UPLC I class Plus. STYROS® R Polymeric Compared with C18 Acquity UPLC® BEH. Folow up Study of App. Note 150.
- 152:Trap, Concentrate and Map, Using Acquity UPLC I class Plus. STYROS® R Polymeric Compared with C18 Acquity UPLC® BEH. Folow up Study of App. Note 150, 151.
Mixed Mode Chromatography or MMC
168. Mixed-Mode Stationary Phase compared with Polymeric Reversed Phase: STYROS® HQ-C8 versus STYROS® 1R.